Company profile: Mobilion Systems
1.1 - Company Overview
Company description
- Provider of high-resolution ion mobility mass spectrometry and targeted molecular analyses to identify and analyze challenging molecules that other instruments so far have failed to detect. Offers MOBIE for rapid, high-resolution separation and identification, plus targeted lipidomics, targeted proteomics, glycomics, metabolomics, and therapeutic oligonucleotide analysis for disease research, diagnostics, biomarker discovery, and therapeutic development.
Products and services
- MOBIE: High-resolution ion mobility mass spectrometry platform that separates and identifies challenging molecules with high resolution and speed, outperforming other instruments that have failed to detect them
- Targeted Proteomics: Targeted capability enabling precise protein characterization for advanced biomarker discovery and therapeutic development in disease research
- Metabolomics: Quantitative analysis supporting metabolite identification and quantification for disease research and biomarker discovery, using targeted measurement of metabolites
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mobilion Systems
Dyadic
HQ: United States
Website
- Description: Provider of microbial protein production platforms and bio-based chemicals. Offers the C1 Platform for developing and manufacturing vaccines, antibodies, and therapeutic proteins for human and animal health; the Dapibus Platform for rapid, large-scale non-pharmaceutical proteins for food and nutrition; recombinant HSA, alpha-lactalbumin, and transferrin; and the DYAI-100 COVID-19 vaccine candidate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dyadic company profile →
Numerate
HQ: United States
Website
- Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Numerate company profile →
MILabs
HQ: The Netherlands
Website
- Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MILabs company profile →
Brooks Running
HQ: United States
Website
- Description: Provider of automation, vacuum, and instrumentation solutions for the worldwide semiconductor manufacturing industry, including wafer handling robotics and integrated tool automation systems, vacuum and atmospheric robots, configurable transfer and transport platforms (MagnaTran LEAP, Marathon LEAP AX, Marathon Express), and pathology lab automation (PathFinder Benchtop, Tube Decapper).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brooks Running company profile →
GenScript
HQ: United States
Website
- Description: Provider of contract research services specialized in biological research and drug discovery/development, offering gene synthesis with expression optimization, cloning and subcloning, plasmid DNA preparation for research, industrial and clinical applications, custom CRISPR-Cas9 gene editing, peptide synthesis, and ToxinSensor kits for sensitive, low-cost endotoxin detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenScript company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mobilion Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mobilion Systems
2.2 - Growth funds investing in similar companies to Mobilion Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mobilion Systems
4.2 - Public trading comparable groups for Mobilion Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →